Bookmark Menu

  • In 2013, a case of HIV remission was reported in a U.S. born child (known as the “Mississippi Baby”) who was treated with three drug ART by 31 hours of life for high-risk HIV exposure from a mother with untreated HIV infection. In this infant, viral load detection reached undetectable levels by 28 days of […]

  • HIV Vaccine Trials Network (HVTN) Executive Director, James Kublin, MD, MPH, lead a one-day training on 3 October 2014, in Harare, aimed at orienting Zimbabwe national regulators to the work of the HVTN, the P5 Initiative in Southern Africa, and Phase I clinical trials the network is planning for implementation in the region.  The P5 […]

  1. 1
  2. 2
  3. 3
  4. 4

UZ-UCSF Collaborative Research Programme

The University of Zimbabwe-University of California San Francisco Collaborative Research Program (UZ-UCSF) was established in 1994 to implement high quality science addressing HIV prevention and therapy; its aim is to control Zimbabwe’s HIV/AIDS epidemic and contribute to global policy as a center of excellence at the University of Zimbabwe College of Health Sciences (UZCHS) in collaboration with UCSF and its partner institutions.

Over the last 20 years, the program has developed a governance structure built on principles of inclusiveness and collaboration of scientific, community, and administrative functions, coupled with efficiency and transparency in resource allocation. A wide range of research collaborations between the institutions have been developed, whereby faculty and staff work closely together in the development and execution of new innovative research. We are pushing our already effective governance structures to establish more open mechanisms for generating new research initiatives in both public and private sectors.

More about UZ-UCSF Our Research


No thumbnail available

NIH-sponsored study identifies superior drug regimen for preventing mother-to-child HIV transmission

November 20th, 2014

For HIV-infected women in good immune health, taking a three-drug regimen during pregnancy prevents mother-to-child HIV transmission more effectively than taking one drug during pregnancy, another during labor and twoRead More

HPTN 076: Injectable PrEP

HPTN 076: Injectable PrEP

November 14th, 2014

Client-centered models of HIV prevention for women which employ Pre Exposure Prophylaxis (PrEP) examine both drug effectiveness but also drug delivery. It has become critical to understand whether available deliveryRead More